Fabrice HÉRIN - Publications
Vous êtes ici :
- Accueil UMR 1295
- Les équipes de recherche
- Equipe 5
EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY
Equipe constitutive du CERPOP, UMR 1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
2022
- Bouhanick B, Brusq C, Bongard V, Tessier S, Montastruc JL, Senard JM, Montastruc F, Herin F. Blood pressure measurements after mRNA-SARS-CoV-2 tozinameran vaccination: a retrospective analysis in a university hospital in France. J Hum Hypertens. 2022 Jun;36(6):580-581. doi: 10.1038/s41371-021-00634-0.
- Conte C, Vayr F, Pajiep MC, Despas F, Huguet F, Mestre ML, Gauthier M, Herin F. Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study. Support Care Cancer. 2022 Jun;30(6):5431-5440. doi: 10.1007/s00520-022-06968-w.
- Dimeglio C, Herin F, Da-Silva I, Gernigon C, Porcheron M, Chapuy-Regaud S, Izopet J. Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant. Microbiol Spectr. 2022 Aug 31;10(4):e0270621. doi: 10.1128/spectrum.02706-21.
- Dimeglio C, Herin F, Martin-Blondel G, Miedougé M, Izopet J. Antibody titers and protection against a SARS-CoV-2 infection. J Infect. 2022 Feb;84(2):248-288. doi: 10.1016/j.jinf.2021.09.013.
- Dimeglio C, Migueres M, Chapuy-Regaud S, Da-Silva I, Jougla I, Pradere C, Porcheron M, Martin-Blondel G, Lougarre C, Herin F, Izopet J. Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response. J Infect. 2022 Jul;85(1):e4-e6. doi: 10.1016/j.jinf.2022.05.001.
- Dimeglio C, Trémeaux P, Herin F, Da-Silva I, Porcheron M, Martin-Blondel G, Gernigon C, Chapuy-Regaud S, Villars H, Izopet J. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population. J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.08.040.
- Dimeglio C, Migueres M, Bouzid N, Chapuy-Regaud S, Gernigon C, Da-Silva I, Porcheron M, Martin-Blondel G, Herin F, Izopet J. Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection. Vaccines (Basel). 2022 Sep 17;10(9):1548. doi: 10.3390/vaccines10091548.
- Dimeglio C, Herin F, Da-Silva I, Porcheron M, Martin-Blondel G, Chapuy-Regaud S, Izopet J. Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration. Clin Infect Dis. 2022 Aug 24;75(1):e924-e925. doi: 10.1093/cid/ciab984.
2021
- Bouhanick B, Montastruc F, Tessier S, Brusq C, Bongard V, Senard JM, Montastruc JL, Herin F. Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal. Eur J Clin Pharmacol. 2021 Dec;77(12):1937-1938. doi: 10.1007/s00228-021-03197-8.
- Dimeglio C, Herin F, Da-Silva I, Porcheron M, Martin-Blondel G, Chapuy-Regaud S, Izopet J. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration. Clin Infect Dis. 2021 Nov 27:ciab984. doi: 10.1093/cid/ciab984. Epub ahead of print.
- Dimeglio C, Herin F, Da-Silva I, Jougla I, Pradere C, Porcheron M, Martin-Blondel G, Chapuy-Regaud S, Izopet J. Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2. Clin Infect Dis. 2021 Aug 12:ciab705. doi: 10.1093/cid/ciab705.
- Dimeglio C, Herin F, Da-Silva I, Porcheron M, Martin-Blondel G, Miedougé M, Izopet J. Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine. Clin Infect Dis. 2021 Jun 22:ciab573. doi: 10.1093/cid/ciab573. Epub ahead of print.
- Dimeglio C, Herin F, Martin-Blondel G, Miedougé M, Izopet J. Antibody titers and protection against a SARS-CoV-2 infection. J Infect. 2021 Sep 21:S0163-4453(21)00483-7. doi: 10.1016/j.jinf.2021.09.013. Epub ahead of print.
- Dimeglio C, Herin F, Miedougé M, Cambus JP, Abravanel F, Mansuy JM, Soulat JM, Izopet J. Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France. J Infect. 2021 Jan;82(1):e29-e32. doi: 10.1016/j.jinf.2020.09.035.
- Dimeglio C, Herin F, Miedougé M, Martin-Blondel G, Soulat JM, Izopet J. Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection. Clin Infect Dis. 2021 Oct 5;73(7):1323-1324. doi: 10.1093/cid/ciab069.
- Dimeglio C, Loubes JM, Miedougé M, Herin F, Soulat JM, Izopet J. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics. Sci Rep. 2021 Jun 15;11(1):12597. doi: 10.1038/s41598-021-92131-0.
- Herin F, Othenin J, Jouanjus E, Rousseau V, Niezborala M, Lapeyre-Mestre M. Evolution of medication consumption in a working environment in France: Results of the four waves of the "Drugs and Work" study (1986-2016). Pharmacoepidemiol Drug Saf. 2021 May;30(5):661-668. doi: 10.1002/pds.5211.
- Hérin F, Savall F, Saint-Martin P, Telmon N. Réparation du dommage en cancérologie [Compensation of damage in cancerology]. Bull Cancer. 2021 Apr;108(4):352-358. French. doi: 10.1016/j.bulcan.2020.11.021.
- Matrat M, Gain M, Haioun C, Le Bras F, Nisse C, Morschhauser F, Clin B, Baldi I, Verdun-Esquer C, Garnier R, Laborde-Castérot H, Hérin F, Esquirol Y, Andujar P, Belacel M, Chouaïd C, Chauvet C, Lasfargues G, Pairon JC. Development of a Questionnaire for the Search for Occupational Causes in Patients with Non-Hodgkin Lymphoma: The RHELYPRO Study. Int J Environ Res Public Health. 2021 Apr 11;18(8):4008. doi: 10.3390/ijerph18084008.
- Vayr F, Montastruc M, Savall F, Despas F, Judic E, Basso M, Dunet C, Dalenc F, Laurent G, Soulat JM, Herin F. Work adjustments and employment among breast cancer survivors: a French prospective study. Support Care Cancer. 2020 Jan;28(1):185-192. doi: 10.1007/s00520-019-04799-w.
- De Barros S, Vayr F, Despas F, Strumia M, Podevin C, Gauthier M, Delabesse E, Soulat JM, Laurent G, Huguet F, Herin F. The impact of chronic myeloid leukemia on employment: the French prospective study. Ann Hematol. 2019 Mar;98(3):615-623. doi: 10.1007/s00277-018-3549-5.
- Vayr F, Herin F, Jullian B, Soulat JM, Franchitto N. Barriers to seeking help for physicians with substance use disorder: A review. Drug Alcohol Depend. 2019 Jun 1;199:116-121. doi: 10.1016/j.drugalcdep.2019.04.004.
- Vayr F, Montastruc M, Savall F, Despas F, Judic E, Basso M, Dunet C, Dalenc F, Laurent G, Soulat JM, Herin F. Work adjustments and employment among breast cancer survivors: a French prospective study. Support Care Cancer. 2020 Jan;28(1):185-192. doi: 10.1007/s00520-019-04799-w.
- Vayr F, Savall F, Bigay-Game L, Soulat JM, Chouaid C, Herin F. Lung cancer survivors and employment: A systematic review. Lung Cancer. 2019 May;131:31-39. doi: 10.1016/j.lungcan.2019.03.010.